Atlas Trials

A Pilot Study of Creatine Monohydrate as an Augmenting Agent for ECT in Persons With Major Depressive Disorder

Clinical trial NCT04504253 · COMPLETED

Trial details

NCT number
NCT04504253
Sponsor
University of Utah
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Major Depressive Disorder
Start date
2020-08-03
Primary completion
2023-08-02
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.